SFX by Ex Libris Inc.

Title:	Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing
Source:	Science [0036-8075] Sisodia, S S yr:1990

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Dobson, Christopher M M. "Protein folding and misfolding." Nature 426.6968 (2003): 884-890.
description	2.	Hardy, J. "The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics." Science 297.5580 (2002): 353-6.
description	3.	Schenk, D. "Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse." Nature 400.6740 (1999): 173-7.
description	4.	HAASS, C. "AMYLOID BETA-PEPTIDE IS PRODUCED BY CULTURED-CELLS DURING NORMAL METABOLISM." Nature 359.6393 (1992): 322-325.
description	5.	Grimm, M. "Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin." Nature cell biology 7.11 (2005): 1118-23.
description	6.	Selkoe, Dennis J J. "Folding proteins in fatal ways." Nature 426.6968 (2003): 900-904.
description	7.	Selkoe, D J J. "Alzheimer's disease: genes, proteins, and therapy." Physiological reviews 81.2 (2001): 741-66.
description	8.	Hardy, J A A. "Alzheimer's disease: the amyloid cascade hypothesis." Science 256.5054 (1992): 184-5.
description	9.	Tycko, R. "Progress towards a molecular-level structural understanding of amyloid fibrils." Current opinion in structural biology 14.1 (2004): 96-103.
description	10.	Yednock, T. "Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease." Nature medicine 6.8 (2000): 916-9.
description	11.	Dobson, Christopher M M. "Principles of protein folding, misfolding and aggregation." Seminars in cell & developmental biology 15.1 (2004): 3-16.
description	12.	Hayer Hartl, M. "Molecular chaperones in protein folding and proteostasis." Nature 475.7356 (2011): 324-332.
description	13.	Dobson, F. "Protein Misfolding, Functional Amyloid, and Human Disease." Annual review of biochemistry 75.1 (2006): 333-366.
description	14.	Blennow, K. "Alzheimer's disease." The lancet 368.9533 (2006): 387-403.
description	15.	Cummings, Jeffrey L L. "Alzheimer's disease." The New England journal of medicine 351.1 (2004): 56-67.
description	16.	Cohen, Fred E E. "Therapeutic approaches to protein-misfolding diseases." Nature 426.6968 (2003): 905-909.
description	17.	Shoji, M. "Production of the Alzheimer amyloid beta protein by normal proteolytic processing." Science 258.5079 (1992): 126-9.
description	18.	Bergeron, C. "A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease." Nature 408.6815 (2000): 979-82.
description	19.	Morgan, D. "A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease." Nature 408.6815 (2000): 982-5.
description	20.	Markham, P. "Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report." Nature medicine 9.4 (2003): 448-52.